Hematologic malignancies in XLA patients
| Types of hematologic malignancy . | HSCT . | Age at cancer diagnosis (years) . | Outcome . | References . |
|---|---|---|---|---|
| Lymphoma | ND | ND | ND | (119) |
| Lymphoma | ND | ND | ND | (95) |
| AML | PBSCT | 13 | Alive | (115) |
| T-LGLL | No | 47 | Alive | (116) |
| CD8+ granulomatous cutaneous T-cell lymphoma | ND | 33 | Alive | (117) |
| Primary cutaneous peripheral T-cell lymphoma | No | 28 | Alive | (122) |
| CD8+ T-cell lymphoma | PBSCT | 24 | Alive | (121) |
| ALL | No | 3 | Dead | (124) |
| NHL | No | 12 | Alive | (118) |
| BCP-ALL | No | 10 | Alive | (114, 120) |
| BCP-ALL | PBSCT | 24 | Alive | (114, 123) |
| AMKL | No | 9 mo | Alive | (114) |
| Types of hematologic malignancy . | HSCT . | Age at cancer diagnosis (years) . | Outcome . | References . |
|---|---|---|---|---|
| Lymphoma | ND | ND | ND | (119) |
| Lymphoma | ND | ND | ND | (95) |
| AML | PBSCT | 13 | Alive | (115) |
| T-LGLL | No | 47 | Alive | (116) |
| CD8+ granulomatous cutaneous T-cell lymphoma | ND | 33 | Alive | (117) |
| Primary cutaneous peripheral T-cell lymphoma | No | 28 | Alive | (122) |
| CD8+ T-cell lymphoma | PBSCT | 24 | Alive | (121) |
| ALL | No | 3 | Dead | (124) |
| NHL | No | 12 | Alive | (118) |
| BCP-ALL | No | 10 | Alive | (114, 120) |
| BCP-ALL | PBSCT | 24 | Alive | (114, 123) |
| AMKL | No | 9 mo | Alive | (114) |
HSCT, hematopoietic stem cell transplantation; ND, no data; AML, acute myeloid leukemia; PBSCT, peripheral blood stem cell transplantation; T-LGLL, T-cell large granular lymphocytic leukemia; ALL, acute lymphoblastic leukemia; NHL, non-Hodgkin lymphoma; BCP, B-cell precursor; AMKL, acute megakaryoblastic leukemia.